Marc Oliva

14PUBLICATIONS
84CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 15, 2026
Baseline Nutritional Status and Early Treatment Response in Oropharyngeal Cancer: A Prospective Cohort Study by HPV Status (FIS 19 Study).

|Jul 14, 2026
Integration of palliative care in a multidisciplinary head and neck cancer clinic: A prospective cohort study.

|Jun 08, 2026
Phase I trial of intravenous VCN-01 oncolytic adenovirus and durvalumab in patients with head and neck metastatic squamous cell carcinoma refractory to immunotherapy.

|May 26, 2026
Integration of Patient-Reported Outcome Measures in Clinical Practice for Head and Neck Cancer Patients: A Cross-Sectional Survey.

|Apr 09, 2026
Phase 1b study of ABBV-368, tilsotolimod, budigalimab, and nab-paclitaxel in patients with recurrent/metastatic head and neck squamous cell carcinoma.

Amaury Daste, Xiuning Le, Amani Makkouk

|Aug 28, 2025
The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target Therapy.

Daria Maria Filippini, Donatella Romaniello, Francesca Carosi

Pageof 3

Frequent Collaborators

4 joint publications

Lillian Siu

3 joint publications

Anna Spreafico

3 joint publications

Jesus Brenes Castro

2 joint publications

Lorena Arribas